Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 564-566

  Paciaroni, Maurizio ^a   Agnelli, Giancarlo ^a   Ageno, Walter ^b   Caso, Valeria ^a   Corea, Francesco ^c,d   Lanari, Alessia ^e   Alberti, Andrea ^a   Previdi, Paolo ^e   Fedele, Marta ^a   Manina, Giorgia ^a   Vedovati, Cristina ^a   Venti, Michele ^a   Billeci, Antonia M R ^a   Batta, Maurizio ^a   Galli, Luca ^b   Silvestrelli, Giorgio ^e  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d S Giovanni Battista Hospital   (Italy)

^e CARLO POMA HOSPITAL   (Italy)

Author keywords

Anticoagulant; Atrial fibrillation; Stroke prevention

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; STROKE; WARFARIN;

EID: 77957710542     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.016     Document Type: Article

References (10)

1. Albers G.W. Atrial fibrillation and stroke: three new studies, three remaining questions. Arch Intern Med 1994, 154:1443-1448.
2. Paciaroni M., Silvestrelli G., Caso V., et al. Neurovascular territories involved in different etiological subtype of ischemic stroke in the Perugia Stroke Registry. Eur J Neurol 2003, 10:361-365.
3. Alexandrov A.V., Brodie D.S., McLean A., et al. Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke 1997, 28:339-342.
4. Eliasziw M., Rankin R.N., Fox A.J., Haynes R.B., Barnett H.J.M. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. Stroke 1995, 26:1747-1752.
5. SPSS for windows 13.0 2004, SPSS Inc., Chicago.
6. Chang Y.J., Ryu S.J., Lin S.K. Carotid artery stenosis in ischemic stroke patients with nonvalvular atrial fibrillation. Cerebrovasc Dis 2002, 13(1):16-20.
7. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989, 320:904-910.
8. Bellosta S., Ferri N., Bernini F., Paoletti R., Corsini A. Non-lipid-related effects of statins. Ann Med 2000, 32:164-176.
9. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559. SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) trial Investigators.
10. Amarenco P., Goldstein L.B., Messig M., et al. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke 2009, 40:2486-2492.